The way forward for Ketamine and Mood Disorders In 2019, the FDA and European Commission approved the use of an esketamine nasal spready underneath the manufacturer name Spravato to treat depression. Nonetheless, as of 2021, ketamine has not been authorized through the FDA to treat depression or other psychological health disorders, and so, the med